- Conditions
- Adenocarcinoma, Borderline Resectable, Carcinoma, +9 more
- Locations
-
- Amsterdam University Medical Center Amsterdam, Netherlands
Clinical trial condition
Extrahepatic Cholangiocarcinoma
Explore clinical trials studying Extrahepatic Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.
7 public trials
6 recruiting studies
Extrahepatic Cholangiocarcinoma trial results
NCT06101277
- Conditions
- Adenocarcinoma, Appendiceal Cancer, Appendiceal Neoplasms, +28 more
- Locations
-
- University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
NCT07641036
- Conditions
- Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +14 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
NCT07235007
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +9 more
- Locations
-
- Aichi Medical University Aichi, Japan
- Nagoya City University Hospital Aichi, Japan
- Nagoya City University Midori Municipal Hospital Aichi, Japan
- Gifu University Hospital Gifu, Japan
Recruiting
Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma
NCT06440993
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
- Locations
-
- Uniklinik RWTH Aachen Aachen, Germany
- Universitätsklinikum Bonn Bonn, Germany
- Universitätsklinikum Köln Cologne, Germany
- Universitätsklinikum Düsseldorf Düsseldorf, Germany
NCT07176962
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +21 more
- Locations
-
- Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, Shanghai Municipality, China
Not yet recruiting
Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer
NCT07793253
- Conditions
- Adenocarcinoma, Ampulla of Vater Carcinoma, Ampullary Carcinoma, +25 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States